Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue:
Total revenue	$ 38,407	$ 28,097
Cost of revenue:
Gross (loss) profit	(1,788)	3,956
Operating expenses:
Research and development	3,592	2,442
Sales and marketing	6,018	3,301
General and administrative	7,226	4,388
Total operating expenses	16,836	10,131
Loss from operations	(18,624)	(6,175)
Other income (expense)
Interest expense, convertible note - related party	(819)
Interest expense, net	(41)	(75)
Total other income (expense), net	(860)	(75)
Net loss	$ (19,484)	$ (6,250)
Net loss per share:
Basic and diluted	$ (0.59)	$ (0.22)
Weighted-average common shares outstanding:
Basic and diluted	32,940,040	27,983,470
Product [Member]
Revenue:
Total revenue	$ 38,330	$ 28,056
Cost of revenue:
Cost of revenue	40,171	24,129
Research Services [Member]
Revenue:
Total revenue	77	41
Cost of revenue:
Cost of revenue	$ 24	$ 12